Robert S. DiPaola, MD, Appointed New Director of CINJ

William F. Owen, Jr., MD
President, University of Medicine and Dentistry of New Jersey

This afternoon, we had the distinct pleasure to announce the appointment of Robert S. DiPaola, MD, as the new Director of The Cancer Institute of New Jersey (CINJ). Dr. DiPaola, a clinician and researcher at CINJ since 1994, was selected following a national search that began in 2007.

Dr. DiPaola is one of the nation’s leading researchers in the area of prostate, bladder and kidney cancers. His leadership and his expertise in translating research from the laboratory to the bedside will help CINJ continue its mission of excellence in both cancer care and cures. His proven expertise in the field of oncology will spur continued growth at CINJ and help to attract even more talented researchers to our university. We are excited about Dr. DiPaola’s commitment to extending CINJ’s service and expertise throughout the State

Dr. DiPaola is a tenured professor of medicine at the UMDNJ-Robert Wood Johnson Medical School and chairs a National Cancer Institute committee with responsibility for the development of national and international clinical trials for treatments of prostate, kidney, bladder and testicular cancers.

Please join us in congratulating Dr. DiPaola as he leads CINJ to take New Jersey’s only National Cancer Institute designated Comprehensive Cancer Center to even greater successes in the future.

William F. Owen, Jr., M.D.
President

Peter S. Amenta, MD, PhD
Interim Dean
UMDNJ - Robert Wood Johnson Medical School